冠状动脉CT血管成像在射血分数保留的心力衰竭患者中的预后价值
该前瞻性研究纳入6497例接受CCTA和超声心动图检查的参与者,其中3096例为HFpEF。中位随访11.0年发现,HFpEF患者冠状动脉粥样硬化患病率更高(78.3% vs 64.9%),且CAD-RADS分级与MACEs风险相关:CAD-RADS 1-2增加非致命性心肌梗死风险(调整HR 2.5),CAD-RADS≥3增加心血管死亡(调整HR 3.9)和心衰住院(调整HR 3.1)风险。
要点
- HFpEF患者冠状动脉粥样硬化患病率高达78.3%,显著高于无HFpEF者。
- HFpEF患者中CAD-RADS 1-2与未来非致命性心肌梗死风险独立相关。
- HFpEF患者中CAD-RADS≥3与心血管死亡和心衰住院风险独立相关。
关键影像表现/征象
- HFpEF组冠状动脉粥样硬化患病率高于无HFpEF组(78.3% vs 64.9%,p<0.001)。
- HFpEF组的中位CACS和CAD-RADS分级均高于无HFpEF组(p均<0.001)。
诊断标准与关键数值
- 在HFpEF患者中,以CAD-RADS=0为参照,CAD-RADS=1-2增加非致命性MI风险(调整HR 2.5,95%CI 1.5-4.3,p<0.001)。
- 在HFpEF患者中,以CAD-RADS=0为参照,CAD-RADS≥3增加心血管死亡风险(调整HR 3.9,95%CI 2.2-7.1,p<0.001)。
- 在HFpEF患者中,以CAD-RADS=0为参照,CAD-RADS≥3增加心衰住院风险(调整HR 3.1,95%CI 1.9-5.3,p<0.001)。
临床应用与阅片要点
- 对HFpEF患者进行CCTA检查时,应详细评估并报告CAD-RADS分级,以识别高风险患者。
- CAD-RADS 1-2提示非致命性MI风险增加,CAD-RADS≥3提示心血管死亡和心衰住院风险增加,可辅助临床决策。
局限性
- 研究为单中心前瞻性队列,结果外推需谨慎。
- 未报告CCTA扫描设备参数、对比剂方案及图像判读一致性等信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the prognostic value of coronary CT angiography (CCTA) in heart failure patients with preserved ejection fraction (HFpEF).
METHODS: Between January 2009 and December 2013, 6497 participants (mean age 63 ± 9.4 [range 32-86] years; 4111 men) who underwent CCTA and echocardiography were prospectively included. Participants were divided into HFpEF group and without HFpEF group. The primary endpoint was major adverse cardiovascular events (MACEs), including cardiovascular mortality, nonfatal myocardial infarction (MI), or hospitalization for heart failure (HF).
RESULTS: Among those participants, 3096 were identified with HFpEF and 3401 were without HFpEF. Higher prevalence of coronary atherosclerosis was observed in HFpEF group than those without (78.3% vs. 64.9%, p < 0.001). During a median of 11.0 [IQR: 9.0-12.0] years follow-up, participants with HFpEF exhibit a heightened risk of MACEs in CAD-RADS = 0, 1-2, and ≥ 3 respectively (p < 0.001 for all). In the risk-adjusted hazard analysis among participants with HFpEF, CAD-RADS = 1-2 increased a 2.5-time risk for non-fatal MI (adjusted HR: 2.5, 95% CI: 1.5 to 4.3, p < 0.001), while CAD-RADS ≥ 3 conferred 3.9-fold and 3.1-fold higher risk for cardiovascular mortality (adjusted HR: 3.9, 95% CI: 2.2 to 7.1, p < 0.001) and hospitalization due to HF (adjusted HR: 3.1, 95% CI: 1.9 to 5.3, p < 0.001) with reference to CAD-RADS = 0 respectively.
CONCLUSIONS: Coronary artery disease is common in participants with HFpEF and associated with MACEs. Among those participants, the presence of CAD-RADS = 1-2 increased the risk of nonfatal MI, while CAD-RADS ≥ 3 were correlated with cardiovascular mortality and hospitalization due to HF.
KEY POINTS: • Higher median of CACS and higher CAD-RADS categories were observed in the HFpEF group than those without (p < 0.001 for both). • Participants with HFpEF exhibit a heightened risk of MACEs in CAD-RADS = 0, 1-2, and ≥ 3 respectively (p < 0.001 for all). • In the risk-adjusted hazard analysis among participants with HFpEF, CAD-RADS =1-2 increased a 2.5-time risk for non-fatal MI (adjusted HR: 2.5, 95% CI: 1.5 to 4.3, p < 0.001) with reference to CAD-RADS = 0 respectively.
引用
- Yu, Zuo, Zhao, et al. Prognostic value of coronary CT angiography in heart failure patients with preserved ejection fraction. Eur Radiol. 2023. PMID: 36629927. doi:10.1007/s00330-022-09380-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。